Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly)

PFE 25.04

+2.6%

Nov 21 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Anthony Wong who wrote (1281)	1/7/1999 5:08:00 PM
From: Sonki	Read Replies (1) of 1722

mrk & wla: Southeast Research Partners said it lowered its rating on shares > of MERCK & CO (153-1/8, down 9/16 @ 10:37 a.m. ET) and ABBOTT LABS > (48-1/8, down 5/16) to hold from buy based on valuation. Analysts > Neil Sweig and Le Anne Zhao believe shares are fully valued based > on earnings expectations for 1999 and 2000. warner-Lambert (WLA) 75 3/8 +1 1/8: CS First Boston maintains "hold" rating on diversified health care company as significant earnings growth expectations for 1998 and 1999 already anticipated by the market; increasing payouts to Pfizer (PFE 125 1/16 -1 1/4) for Lipitor could also rein in profit acceleration; valuation increasingly dependent on Lipitor, which is expected to represent 40% of sales in 2001; few near-term catalysts as diabetes drug Rezulin, company's second largest product, faces slowing growth and potential competition in the near-term.....

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next